In 2025, the healthcare landscape in the United States is evolving rapidly, blending innovation in pharmaceutical research with ongoing debates around ivermectin USA. One of the most notable developments this year is the advancement of Boehringer Ingelheim lung therapy trends USA, alongside the continuous rise in discussions about ivermectin and its role in patient care. This blog...